Recommended
product-img
  • Products
  • Discover MP Targets
  • Discover Research Areas
  • mProX™ Human P2RX7 Stable Cell Line

    [CAT#: S01YF-1023-PY256]
    Product Category:
    Membrane Protein Stable Cell Lines
    Subcategory:

    Datasheet MSDS Request COA

    Certificate of Analysis Lookup
    To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
    Lot Number

    Made to Order Inquiry

    Inquiry
    Host Cell Type:
    Membrane Protein Engineering:
    Fluorescent Marker:
    Resistance:
    Deliverable:

    Product Information

    Target Family
    Other Targets
    Target Protein Species
    Human
    Host Cell Type
    HEK293;CHO-K1;HT22
    Target Classification
    Other Targets Drug Discovery Assays and Products
    Target Research Area
    Infectious Research
    Related Diseases
    Tularemia; Gout
    Gene ID
    Human:5027
    UniProt ID
    Human:Q99572

    Product Properties

    Biosafety Level
    Level 1
    Activity
    Yes
    Quantity
    10⁶ cells per vial
    Applications
    The P2RX7 gene has various applications in different fields. In the field of gastric cancer, P2RX7 is one of the genes that is hypermethylated in gastric mucosa infected with Helicobacter pylori, and its methylation is associated with specific molecular and clinicopathological features of gastric cancer. In the field of complex regional pain syndrome type 1 (CRPS-1), P2RX7 is one of the genes associated with a genetic background predisposing to the condition. In hypertension research, P2RX7 activation has been found to contribute to hypertension and cardiovascular injury by promoting immune activation, and its knockout or antagonism reduces hypertension, vascular injury, and immune cell activation. Additionally, P2RX7 has been studied in the context of chiral separation of lactam-based P2RX7 antagonists and as a target for reducing graft-versus-host disease in humanized mice.

    Protocols

    Please visit our protocols page.

    Customer Reviews

    There are currently no Customer reviews or questions for mProX™ Human P2RX7 Stable Cell Line (S01YF-1023-PY256). Click the button above to contact us or submit your feedback about this product.

    FAQ

    chat Taylor Jones (Verified Customer)

    How do P2RX7 polymorphisms affect receptor function? Feb 03 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Certain P2RX7 single nucleotide polymorphisms can promote exon skipping, leading to disrupted receptor function by affecting the ATP-binding site. Feb 03 2021

    chat Alex Garcia (Verified Customer)

    What is the role of P2RX7 in tumor control by CD8+ T cells? Sep 25 2021

    chat Patrick Liam (Creative Biolabs Scientific Support)

    Activation of P2RX7 enhances the control of melanoma by CD8+ T cells in adoptive cell therapy, indicating its importance in tumor elimination and immunotherapy. Sep 25 2021

    Published Data

    Fig.1 P2rx7 was subdued within HT-22 cells, experiencing a knockdown.

    Quantitative analysis of P2rx7 expression in P2rx7-knockdown HT-22 hippocampal neurons, which were overexpressed with Pja2, was conducted using (q)RT-PCR. The means ± SD were derived from 3 biological replicates, and a statistical significance of P < 0.01 was observed when compared to the scramble group.

    Ref: Gong, Mengting, et al. "Regulatory function of praja ring finger ubiquitin ligase 2 mediated by the P2rx3/P2rx7 axis in mouse hippocampal neuronal cells." American Journal of Physiology-Cell Physiology 318.6 (2020): C1123-C1135.

    Pubmed: 32267716

    DOI: 10.1152/ajpcell.00070.2019

    Research Highlights

    Tahara, Sayumi. et al. "Helicobacter pylori infection associated DNA methylation in primary gastric cancer significantly correlates with specific molecular and clinicopathological features." Molecular carcinogenesis, 2023.
    The study aimed to examine the association between Helicobacter pylori-induced DNA methylation and CpG island methylator phenotype (CIMP) in gastric cancer (GC) as well as its molecular subtypes and clinical features. A total of 624 gastric tissue samples were analyzed, including 217 primary GC, 217 adjacent mucosa, and 190 mucosae from cancer-free subjects. Five genes (IGF2, SLC16A2, SOX11, P2RX7, and MYOD1) were identified as hypermethylated in H. pylori infected gastric mucosa. Non-neoplastic mucosa from patients with GC showed higher methylation of H. pylori infection associated genes compared to those without GC. In primary GC tissues, higher methylation of these genes was correlated with CIMP-positive and related features such as MLH1 methylation. On the other hand, GC with lower methylation of these genes presented aggressive clinicopathological features. This suggests that H. pylori infection-associated DNA methylation may serve as a potential biomarker for GC.
    Tahara, Sayumi. et al. "Helicobacter pylori infection associated DNA methylation in primary gastric cancer significantly correlates with specific molecular and clinicopathological features." Molecular carcinogenesis, 2023.
    Pubmed: 37846801   DOI: 10.1002/mc.23650

    S Shaikh, Samiha. et al. "Evidence of a genetic background predisposing to complex regional pain syndrome type 1." Journal of medical genetics, 2023.
    In the current work, an exploration was conducted to analyze the genetic makeup of patients with chronic complex regional pain syndrome type 1 (CRPS-1) in comparison to those without the disorder. The study focused on the potential differences in genetic profile between the two groups. CRPS-1 is a rare and debilitating condition that frequently occurs following a physical injury. This research aimed to provide valuable insights into the genetic factors that may contribute to the development of CRPS-1.
    S Shaikh, Samiha. et al. "Evidence of a genetic background predisposing to complex regional pain syndrome type 1." Journal of medical genetics, 2023.
    Pubmed: 37816627   DOI: 10.1136/jmg-2023-109236

    Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR CLINICAL PROCEDURES" For licensing inquiries, please contact
    Send Inquiry Send Inquiry
    Inquiry Basket
    compare

    Go to compare